Abstract:Background Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Intrahepatic metastasis, such as portal vein tumor thrombosis (PVTT), strongly indicates poor prognosis of HCC. But now, there are limited understandings of the molecular features and mechanisms of those metastatic HCCs. Methods To characterize the molecular alterations of the metastatic HCCs, we implemented an integrative analysis of the copy number variations (CNVs), DNA methylations and transcriptomes of matched adjacent normal, primary tumor and PVTT samples from 19 HCC patients. Results CNV analysis identified a frequently amplified focal region chr11q13.3 and a novel deletion peak chr19q13.41 containing three miRNAs. The integrative analysis with RNA-seq data suggests that CNVs and differential promoter methylations regulate distinct oncogenic processes. Then, we used individualized differential analysis to identify the differentially expressed genes between matched primary tumor and PVTT of each patient. Results show that 5 out of 19 studied patients acquire evidential progressive alterations of gene expressions (more than 1000 differentially expressed genes were identified in each patient). While, another subset of eight patients have nearly identical gene expressions between the corresponding matched primary tumor and PVTT. Twenty genes were found to be recurrently and progressively differentially expressed in multiple patients. These genes are mainly associated with focal adhesion, xenobiotics metabolism by cytochrome P450 and amino acid metabolism. For several differentially expressed genes in metabolic pathways, their expressions are significantly associated with overall survivals and vascular invasions of HCC patients. The following transwell assay experiments validate that they can regulate invasive phenotypes of HCC cells. Conclusions The metastatic HCCs with PVTTs have significant molecular alterations comparing with adjacent normal tissues. The recurrent alteration patterns are similar to several previously published general HCC cohorts, but usually with higher severity. By an individualized differential analysis strategy, the progressively differentially expressed genes between the primary tumor and PVTT were identified for each patient. A few patients aquire evidential progressive alterations of gene expressions. And, experiments show that several recurrently differentially expressed genes can strongly regulate HCC cell invasions.

The Molecular Cytogenetic Study on the Mechanisms Involved in the Metastasis of Human Hepatocellular Carcinoma

The Association of Chromosome 8p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma.

Advances in Brief The Association of Chromosome 8 p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma 1

Based on Tumor Mutation Burden to construct diagnosis and prognosis models and provides guidance for the treatment in the Hepatocellular Carcinoma patients

Chromosome 8p Deletion is Associated with Metastasis of Human Hepatocellular Carcinoma when High and Low Metastatic Models Are Compared

The Predictive Value of Chromosome 8p Deletion for Metastasis of Hepatocellular Carcinoma: a Summary of Works in 10 Years

Integrative molecular analysis of metastatic hepatocellular carcinoma

Allelic Imbalance Regions on Chromosomes 8p, 17p and 19p Related to Metastasis of Hepatocellular Carcinoma: Comparison Between Matched Primary and Metastatic Lesions in 22 Patients by Genome-Wide Microsatellite Analysis

The Abnormalities of Chromosome 8 in Two Hepatocellular Carcinoma Cell Clones with the Same Genetic Background and Different Metastatic Potential

Chromosomal Aberrations Related to Metastasis of Human Solid Tumors

A Decade's Studies on Metastasis of Hepatocellular Carcinoma.

Functional Localization of Metastasis Suppressor Genes for HCC on Human Chromosome 8

Whole Genome Sequencing of Matched Tumor, Adjacent Non-Tumor Tissues and Corresponding Normal Blood Samples of Hepatocellular Carcinoma Patients Revealed Dynamic Changes of the Mutations Profiles During Hepatocarcinogenesis.

The Molecular Signature of Metastases of Human Hepatocellular Carcinoma

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

FGL1, a Candidate Metastatic Suppressor Gene of Human Hepatocellular Carcinoma

Application of Genechip Technology in Identification of Metastasis-Associated Genes for Hepatocellular Carcinoma

The Predictive Value of Chromosome 8p Deletion for Metastasis of Hepatocellular Carcinoma:A Summary of 10 Years' Works

The Investigation of the Technology of Microcell Mediated Chromosome Transfer for Functional Localization of Metastasis Suppressor Genes for Liver Cancer on Human Chromosomes

Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization

Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma